Change history
27 June 2022
A Correction to this paper has been published: https://doi.org/10.1007/s12311-022-01439-8
References
Baghbanian SM, Mahdavi Amiri MR, Majidi H. Cerebrotendinous xanthomatosis revisited. Pract Neurol. 2021;21:243–5. https://doi.org/10.1136/practneurol-2020-002895.
Nie S, Chen G, Cao X, Zhang Y. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2014;9:179. https://doi.org/10.1186/s13023-014-0179-4.
Raymond GV, Schiffmann R. Cerebrotendinous xanthomatosis: The rare “treatable” disease you never consider. Neurology. 2019;92:61–2. https://doi.org/10.1212/WNL.0000000000006721.
Salen G, Steiner RD. Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX). J Inherit Metab Dis. 2017;40:771–81. https://doi.org/10.1007/s10545-017-0093-8.
Sekijima Y, Koyama S, Yoshinaga T, Koinuma M, Inaba Y. Nationwide survey on cerebrotendinous xanthomatosis in Japan. J Hum Genet. 2018;63:271–80. https://doi.org/10.1038/s10038-017-0389-4.
Schmahmann JD. The cerebellum and cognition. Neurosci Lett. 2019;688:62–75. https://doi.org/10.1016/j.neulet.2018.07.005.
Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121:561–79. https://doi.org/10.1093/brain/121.4.561.
Patel N, Anand D, Monies D, Maddirevula S, Khan AO, Algoufi T, et al. Novel phenotypes and loci identified through clinical genomics approaches to pediatric cataract. Hum Genet. 2017;136:205–25. https://doi.org/10.1007/s00439-016-1747-6.
National Center for Biotechnology Information. ClinVar; [VCV000004262.11], https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000004262.11. Accessed 28 Dec 2021.
Argyropoulos GPD, van Dun K, Adamaszek M, Leggio M, Manto M, Masciullo M, et al. The cerebellar cognitive affective/Schmahmann syndrome: a task force paper. Cerebellum. 2020;19:102–25. https://doi.org/10.1007/s12311-019-01068-8.
Manto M, Mariën P. Schmahmann’s syndrome—identification of the third cornerstone of clinical ataxiology. Cerebellum Ataxias. 2015;2:2. https://doi.org/10.1186/s40673-015-0023-1.
Funding
J. Benito-León is supported by the National Institutes of Health, Bethesda, MD, USA (NINDS #R01 NS39422), European Commission (grant ICT-2011-287739, NeuroTREMOR), the Ministry of Economy and Competitiveness (grant RTC-2015-3967-1, NetMD—platform for the tracking of movement disorder), and the Spanish Health Research Agency (grant FIS PI12/01602 and grant FIS PI16/00451).
Author information
Authors and Affiliations
Contributions
All authors contributed significantly to the creation of this manuscript; each fulfilled criterion as established by the ICMJE.
Corresponding author
Ethics declarations
Ethics Approval
Written informed consent was obtained from the patient to publish this case report and any accompanying images.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ghosh, R., León-Ruiz, M., Sardar, S.S. et al. Cerebellar Cognitive Affective Syndrome in a Case of Cerebrotendinous Xanthomatosis. Cerebellum 22, 776–779 (2023). https://doi.org/10.1007/s12311-022-01421-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12311-022-01421-4